Implications of Bacteriophage- and Bacteriophage Component-Based Therapies for the Clinical Microbiology Laboratory | Zendy

Katherine M. Caflisch | Zendy; Robin Patel | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Implications of Bacteriophage- and Bacteriophage Component-Based Therapies for the Clinical Microbiology Laboratory

Author(s) -

Katherine M. Caflisch,

Robin Patel

Publication year - 2019

Publication title -

journal of clinical microbiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.349

H-Index - 255

eISSN - 1070-633X

pISSN - 0095-1137

DOI - 10.1128/jcm.00229-19

Subject(s) - bacteriophage , phage therapy , clinical microbiology , anticipation (artificial intelligence) , microbiology and biotechnology , biology , antibiotic resistance , medicine , virology , intensive care medicine , antibiotics , computer science , genetics , escherichia coli , artificial intelligence , gene

Treatment of bacterial infections is increasingly challenged by resistance to currently available antibacterial agents. Not only are such agents less likely to be active today than they were in the past, but their very use has selected for and continues to select for further resistance. Additional strategies for the management of bacterial illnesses must be identified. In this review, bacteriophage-based therapies are presented as one promising approach.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research